Hallett David (CIK 2006495) reported 5 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-05-19). Recent activity: Sell RXRX (26,657 shares), Sell RXRX (11,908 shares), Buy RXRX (502,064 shares), Buy RXRX (24,254 shares), Sell RXRX (11,400 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-19 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Chief Scientific Officer | Sell | 26,657 | $81,037 |
| 2026-02-19 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Chief Scientific Officer | Sell | 11,908 | $41,559 |
| 2026-02-10 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Chief Scientific Officer | Buy | 502,064 | $0 |
| 2026-02-10 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Chief Scientific Officer | Buy | 24,254 | $0 |
| 2026-02-10 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Chief Scientific Officer | Sell | 11,400 | $45,372 |
Source: SEC Form 4 filings · as of 2026-05-19